01 208VERTEX PHARMS INC
01 47495103
02 47645789
03 47776905
04 98324242
05 58354427
06 48410274
07 98415387
08 98598181
09 48623905
10 98629162
11 48754224
12 28883206
13 39012496
14 99670163
15 99931334
16 99974781
17 510022352
18 910081621
19 910239867
20 410272046
21 410646481
22 910758534
23 910793547
24 411147770
25 811179367
26 811426407
27 411453655
28 811517564
29 811564916
30 811578062
31 811639347
32 411752106
33 212214083
01 67Y
02 141Blank
01 156Y
02 52Blank
01 92025-06-24
02 52026-07-06
03 262026-12-28
04 312027-04-09
05 172027-05-01
06 42027-05-20
07 42027-06-03
08 92027-08-05
09 92027-11-12
10 122029-08-13
11 172031-03-25
12 162033-02-27
13 32033-07-15
14 172035-10-06
15 292037-12-08
Patent Expiration Date : 2033-07-15
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 9012496
Drug Substance Claim :
Drug Product Claim :
Application Number : 212273
Patent Use Code : U-2649
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-07-15
Patent Expiration Date : 2027-04-09
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10022352
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-2651
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2031-03-25
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10081621
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4065
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10081621
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4065
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2027-04-09
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 9974781
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4066
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 9974781
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4066
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2026-12-28
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 9931334
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4068
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-12-28
Patent Expiration Date : 2026-12-28
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 9931334
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4068
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-12-28
Patent Expiration Date : 2026-12-28
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 9670163
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4068
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-12-28
Patent Expiration Date : 2026-12-28
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 9670163
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4068
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-12-28
